Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Olaszország
35 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleStudy of SGR-1505 in Mature B-Cell Neoplasms
- Where
- Alexandria, Milan, Turin, Verona
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00 - No phaseTaking peopleExploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
- Where
- Alessandria, Ancona, Bari, Brescia, Candiolo, Castelfranco Veneto, Catania, Civitanova Marche, Florence, Milan, Padova, Sassuolo, Siena, Torino, Treviso, Tricase, Trieste, Verona
- Életkor
- 18 év to 79 év
- People
- 200
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT06588205 - No phaseTaking peopleMixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)
- Where
- Bologna, Meldola, Ravenna, Rimini
- Életkor
- 18 év and over
- People
- 300
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT04300101 - 2. fázisFut, nem toborozStudy of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure
- Where
- Alexandria, Bologna, Cuneo, Milan, Rome, Rozzano
- Életkor
- 18 év to 99 év
- People
- 50
- Run by
- Istituto Clinico Humanitas
See details and how to joinNCT06918912 · EU 2024-516929-31-00 - No phaseTaking peopleRole of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines
- Where
- Bologna
- Életkor
- 18 év and over
- People
- 160
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06774326 - 3. fázisFut, nem toborozA Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
- Where
- Aviano, Bari, Milan, Monza, Naples, Orbassano, Reggio Calabria, Rome, Trieste, Udine, Verona
- Életkor
- 75 év and over
- People
- 300 worldwide
- Run by
- Nordic Lymphoma Group
See details and how to joinNCT04332822 · EU 2022-502887-19-00 - No phaseTaking peopleStudy to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)
- Where
- Milan
- Életkor
- 18 év and over
- People
- 200
- Run by
- Incyte Biosciences Italy S.r.l
See details and how to joinNCT06299553 - No phaseNot yet taking people in OlaszországPredictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA)
- Where
- Naples, Roma
- Életkor
- 18 év and over
- People
- 300
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT05746858 - 3. fázisBefejeződöttPrephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
- Where
- Alexandria, Ancona, Andria, Ascoli Piceno, Avellino, Aviano, Brescia, Cagliari, Chivasso, Florence, Meldola, Milan, Monza, Novara, Palermo, Pavia, Perugia, Pescara, Piacenza, Ponderano, Potenza, Ravenna, Reggio Emilia, Rimini, Rionero In Vulture, Roma, Rome, Salerno, San Giovanni Rotondo, Sassuolo, Siena, Terni, Trieste, Turin, Udine, Venice, Vicenza
- Életkor
- 65 év and over
- People
- 430
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT04442412 · EU 2024-511637-35-00 - 1/2. fázisTaking peopleSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
- Where
- Aviano, Meldola, Milan, Pavia, Verona
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT04502394